Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229

Product picture of isupatob sodium (formally known as M6229), which is a treatment in clinical development for sepsis. Geleen ...
Nature

Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

Post-translational modifications of histones introduce meaningful variations into chromatin and provide a regulatory platform for controlling and/or fine-tuning many important DNA-templated processes, ...

Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology

Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...
AZoLifeSciences on MSN

PLAMseq revolutionizes simultaneous analysis of genome proteins and their locations

A team from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

One experiment, two insights: Sequencing method reveals both genome proteins and their positions

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...